Trading restenosis for thrombosis? New questions about drug-eluting stents

Article Abstract:

A controversial finding regarding the risk of late thrombosis associated with drug-eluting coronary stents suggested that patients with the Cypher stent had substantially higher rates of death and myocardial infarction than those with bare-metal stent. As clinicians sort through the new information and await the Food and Drug Administration's (FDA's) pronoucements, it has already reduced sales of drug-coated stents while that of bare-metal stents has edged up.

Usage, Heart attack

---

Thrombosis of the cerebral veins and sinuses

Article Abstract:

Thrombosis of the cerebral veins and sinuses is a distinct cerebrovascular disorder that unlike arterial stroke, most often affects young adults and children. An insight into the pathogenesis of sinus thrombosis, risk factors, and clinical and radiologic diagnosis is provided along with the current evidence and controversies about the best treatment.

United Kingdom, Diagnosis, Paranasal sinuses

---

Stent thrombosis redux--The FDA perspective

Article Abstract:

The U.S. Food and Drug Administration (FDA) is planning to review the reports on the risk of thrombosis due to drug-eluting stents in order to examine the safety of the device. The FDA believes that longer studies should be conducted on the safety and efficacy drug-eluting stents as compared to those of alternative treatments.

United States, Reports, United States. Food and Drug Administration

Similar abstracts:

• Abstracts: Progressive prothrombotic state in women with advancing HIV disease. T-cell lymphoma in HIV-infected patients
• Abstracts: Heparin levels to guide thromboembolism prophylaxis during pregnancy
• Abstracts: Creating incentives for genomic research to improve targeting of therapies. Advances in the use of synthetic combinatorial chemistry: mixture-based libraries
• Abstracts: Improving primary care services for people with learning disability. Jane Warner a voice from primary care
• Abstracts: Blood transfusion. Erythropoietin therapy. Anemia of chronic disease

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.